- Non-GAAP(1) operating earnings increased 6 percent to $566 million - Non-GAAP diluted earnings per share (EPS) from continuing operations decreased 9 percent to $1.00
- Prior year first quarter included an $0.18 benefit related to tax settlements; excluding this impact, non-GAAP diluted EPS increased 9 percent DUBLIN, Ohio , Oct.
Accretive Health, Inc. (OTC Pink: ACHI) today announced that, in
connection with the appointment of David Mason as the company’s chief
strategy officer, on November 11, 2014, Accretive Health granted to
Mason a nonstatutory stock option and shares of restricted common stock
(collectively the “Inducement Grants”) as an inducement material to
Mason’s acceptance of employment with the company.
IMS Health Holdings , Inc. (“IMS Health”) (NYSE:IMS), a leading
global provider of information and technology services to the healthcare
and life sciences industries, today announced results for the quarter
ended September 30, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.